HIMSS TV

Medicomp made early coronavirus-specific changes to its database and AI engine as the pandemic took hold in February and has continued to innovate since then, says CEO Dave Lareau.

In this episode of The Alessi Agenda, Dr. Nathalie Bloch, head of big data and AI at the ARC Innovation Center at Sheba Medical Center, Israel, discusses the use of AI in dealing with COVID-19 patients.

Amwell CEO Dr. Roy Schoenberg discusses how COVID-19 has impacted his telehealth company and will continue to shape the future of virtual care.

In this episode of The Alessi Agenda, Woodlands Health Campus CEO Dr. Jason Cheah explains how global examples of EMRs, robotics and telehealth helped accelerate digital transformation in Singapore.

Remote monitoring tech can help reach patients at home and reduce contact with COVID-19-positive patients, says Kuldeep Singh Rajput, CEO and founder of Biofourmis.

Pharmacogenomics is a good entry point for providers in precision medicine, identifying the right medicine for better outcomes and patient satisfaction, according to Joel Diamond, MD, CMO of 2bPrecise.

Technology issues for interoperability are more of a cultural than a deployment challenge, explain Lyniate Chief Product and Strategy Officer Drew Ivan and Life Image CEO Matthew Michela.

Consumer-centric healthcare means patients have access to their cost and data and are part of the discussions about their healthcare options.

Health systems must defend against not only the coronavirus pandemic but also the opportunistic cyberattacks that are using it as cover to sow chaos, says HIMSS Director of Privacy and Security Lee Kim.

The 72-practice Community Care Physicians medical group has used patient engagement tech to improve its no-show rate by 35%, send 776,000 COVID-related newsletters to patients and remind them of their telehealth appointments during the pandemic.